The scaffold protein KSR1, a novel therapeutic target for the treatment of Merlin-deficient tumors

Authors

L. Zhou
J. Lyons-Rimmer
S. Ammoun, Peninsula Medical School
J. Müller, Aston University
E. Lasonder
V. Sharma, School of Biomedical Sciences
E. Ercolano, Peninsula Medical School
D. Hilton, University Hospitals Plymouth NHS Trust
I. Taiwo
M. Barczyk, Medical Research Council
C. O. Hanemann, Peninsula Medical School

ORCID

• S. Ammoun: 0000-0002-1525-3583
• V. Sharma: 0000-0002-3833-7763
• E. Ercolano: 0000-0001-7471-9374
• C. O. Hanemann: 0000-0002-1951-1025

DOI

10.1038/onc.2015.404

Publication Date

2016-06-30

Publication Title

Oncogene

Volume

35

Issue

26

ISSN

0950-9232

Embargo Period

2016-12-30

First Page

3443

Last Page

3453

Recommended Citation

Zhou, L., Lyons-Rimmer, J., Ammoun, S., Müller, J., Lasonder, E., Sharma, V., Ercolano, E., Hilton, D., Taiwo, I., Barczyk, M., & Hanemann, C. (2016) 'The scaffold protein KSR1, a novel therapeutic target for the treatment of Merlin-deficient tumors', Oncogene, 35(26), pp. 3443-3453. Available at: 10.1038/onc.2015.404